Know Your Investor: RA Capital Management (January’25 Edition)

Shots: The January Edition features RA Capital Management, a global multi-stage investment firm dedicated to healthcare and life sciences In 2024, RA Capital added 74 companies to its portfolio, investing approximately $8.5B across seven funding rounds, including private and common funding Welcome to the 2025 series of Know Your Investor, a meticulously crafted report highlighting…

ByPrince GiriJanuary 16, 2025

INSIGHTS+

Know Your Investor: Arch Venture Partners (August’24 Edition)

Shots: In the August Edition of the Know Your Investor series, we bring a condensed yet illuminating report on Arch Venture Partners In 2023, Arch Ventures Partners participated in 6 investment rounds and added 27 companies focusing on biopharma and manufacturing & services to its portfolio For a detailed report on all the investments, reach…

ByPrince GiriAugust 21, 2024

INSIGHTS+

Know Your Investor: Invus (July’24 Edition)

Shots:   Backed with an evergreen investment strategy, Invus makes investments across several company stages ranging from early growth to turnarounds In 2023, Invus participated in 6 investment rounds in around 29 companies focusing on biopharma, manufacturing & services, and devices For a curated report on a specific investor or venture capital, reach out to us…

ByPrince GiriJuly 17, 2024

INSIGHTS+

Know Your Investor (May Edition): Alexandria Venture Investment

Shots: In the May Edition of the Know Your Investor series, we are focussing on Alexandria Venture Investments, an integral part of Alexandria Real Estate Equities In 2023, Alexandria Venture Investments invested in 24 companies; 5, 8, 5 & 6 every quarter across 2023 respectively For a detailed report on all the investments, reach out…

ByPrince GiriMay 28, 2024

INSIGHTS+

Know Your Investor (March Edition): Qiming Venture Partners

Shots: In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and Healthcare In 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…

BySenior EditorMarch 26, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Shots: The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industry In February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative Colitis PharmaShots has compiled a list of a total…

BySenior EditorMarch 20, 2024

INSIGHTS+

Know Your Investor (February Edition): F-Prime Capital Partners

Shots: Know Your Investor is an earnest effort from PharmaShots to acquaint our readers with leading Investors and venture capital firms in the healthcare industry Founded in 1969, F-Prime Capital Partners is a subsidiary of Fidelity Investments and primarily invests in healthcare and technology A total of 40 investments were closed by F-Prime in 2023,…

BySenior EditorFebruary 27, 2024

Know Your Investor: RA Capital Management (January’25 Edition)

Know Your Investor: Arch Venture Partners (August’24 Edition)

Know Your Investor: Invus (July’24 Edition)

Know Your Investor (May Edition): Alexandria Venture Investment

Know Your Investor (March Edition): Qiming Venture Partners

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Know Your Investor (February Edition): F-Prime Capital Partners

Contact US

OUR INFORMATION

FOLLW US

Know Your Investor: RA Capital Management (January’25 Edition)

Know Your Investor: Arch Venture Partners (August’24 Edition)

Know Your Investor: Invus (July’24 Edition)

Know Your Investor (May Edition): Alexandria Venture Investment

Know Your Investor (March Edition): Qiming Venture Partners

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Know Your Investor (February Edition): F-Prime Capital Partners

FOLLW US

Sign Up to Our Newsletter